Cargando…
Identification and validation of a novel CD8+ T cell-associated prognostic model based on ferroptosis in acute myeloid leukemia
Acute myeloid leukemia (AML) is a highly aggressive cancer with great heterogeneity and variability in prognosis. Though European Leukemia Net (ELN) 2017 risk classification has been widely used, nearly half of patients were stratified to “intermediate” risk and requires more accurate classification...
Autores principales: | Jiang, Ge, Jin, Peng, Xiao, Xiao, Shen, Jie, Li, Ran, Zhang, Yunxiang, Li, Xiaoyang, Xue, Kai, Li, Junmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150955/ https://www.ncbi.nlm.nih.gov/pubmed/37138885 http://dx.doi.org/10.3389/fimmu.2023.1149513 |
Ejemplares similares
-
Development and Validation of a Novel Prognostic Model for Acute Myeloid Leukemia Based on Immune-Related Genes
por: Li, Ran, et al.
Publicado: (2021) -
CD26(low)PD-1(+) CD8 T cells are terminally exhausted and associated with leukemia progression in acute myeloid leukemia
por: Zhou, Huarong, et al.
Publicado: (2023) -
Establishment and validation of exhausted CD8+ T cell feature as a prognostic model of HCC
por: Shi, Jihang, et al.
Publicado: (2023) -
Construction and Validation of a Novel Ferroptosis-Related Prognostic Model for Acute Myeloid Leukemia
por: Song, Ying, et al.
Publicado: (2022) -
ITGAL infers adverse prognosis and correlates with immunity in acute myeloid leukemia
por: Li, Ran, et al.
Publicado: (2022)